|
Biography |
|
- Professor of analytical toxicology and head of department at The National Research Center (NRC) 2003, and professor in German university in Cairo (GUC) previously head of department of pharmacology & toxicology; faculty of pharmacy ( 2003-2013).
- Earned my Ph.D from Japan (1993-1997). My Researches have been focused on the developing and application of analytical techniques in the field of toxicology related to drug abuse, ergogenic aids , drug toxicokinetics , genotoxicity of nanoparticles and neurodegenerative diseases therapeutic approaches from natural origin .
- Lately published a number of articles in toxicological assessments of nutraceuticals. Involvement in national & international projects in cooperation with industry, to solve current problems or to innovatively develop market driven products form natural sources such as ; Combating Stunting in Qaliubia Egypt (CO PI, financed by Misr El Kheir Foundation). Rice bran Nutraceuticals and Rice Bran innovative formulation (Partner, Financed by the EU). Pharmaceutical Pectin from Orange Peels (Consultant, financed by Science and Technology Development Fund).
|
|
|
|
Abstract |
|
|
Application of Nanomaterials: Benefits versus Risk” |
|
|
|
For successful application of nanomaterials in bioscience, it is essential to understand the biological fate as well as the potential toxicity of nanoparticles. Nanomaterial safety is becoming an increasingly debatable issue that has intensified over the past several years. The small size and particular shape, large surface area and surface activity, which make nanomaterials attractive in biological applications, may contribute to their toxicological profile. Regarding their safety assessment nanomaterials cannot be treated in the same manner as chemical compounds. Therefore, the establishment of principles and test procedures to ensure the safe use of nanomaterials in the marketplace is urgently required.The present talk includes illustrations to a number of toxicological tests which have a great impact in evaluating the safe use of nonmaterial specially in bioscience . |
|
|
|